Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF)
D R Knighton, K F Ciresi, V D Fiegel, L L Austin, E L Butler, D R Knighton, K F Ciresi, V D Fiegel, L L Austin, E L Butler
Abstract
Previous animal data showed that platelets contain growth factors that stimulate capillary endothelial migration (angiogenesis), fibroblast proliferation and migration, and collagen synthesis. This study utilized autologous platelet-derived wound healing factors (PDWHF) to treat 49 patients with chronic nonhealing cutaneous ulcers. Patients were classified on the basis of 20 clinical and wound status parameters to generate a wound severity index. Forty-nine patients--58% diabetic (20% with renal transplants); 16% with trauma, vasculitis, etc.; 14% with decubitus ulcers; and 6% each with venous stasis or arterial insufficiency--with a total of 95 wounds had received conventional wound care for an average of 198 weeks (range: 1-1820 weeks). After informed consent was obtained, patients received autologous PDWHF. Mean 100% healing time for all patients was 10.6 weeks. There was no abnormal tissue formation, keloid, or hypertrophic scarring. A multivariant analysis showed a direct correlation to 100% healing with initial wound size and the initiation of PDWHF therapy. This is the first clinical demonstration that locally acting growth factors promote healing of chronic cutaneous ulcers.
References
- Ann Surg. 1982 Oct;196(4):379-88
- Proc Natl Acad Sci U S A. 1982 Dec;79(24):7773-7
- Science. 1983 Sep 23;221(4617):1283-5
- Surgery. 1984 Jul;96(1):48-54
- Surgery. 1981 Aug;90(2):262-70
- J Clin Invest. 1985 Dec;76(6):2323-9
- Proc Natl Acad Sci U S A. 1974 Apr;71(4):1207-10
- Adv Enzymol Relat Areas Mol Biol. 1979;48:277-318
- Proc Natl Acad Sci U S A. 1979 Apr;76(4):1809-13
- Cell. 1985 Nov;43(1):277-86
Source: PubMed